Diffuse alveolar damage in patients with dermatomyositis: A six-case series

Modern Rheumatology

Volumn 22, Issue 2, 2012, Pages 243-248

  Matsuki, Yuko ^a   Yamashita, Hiroyuki ^a   Takahashi, Yuko ^a   Kano, Toshikazu ^a   Shimizu, Arisa ^a   Itoh, Kenji ^a   Kaneko, Hiroshi ^a   Mimori, Akio ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Amyopathic dermatomyositis; Dermatomyositis; Diffuse alveolar damage; Interstitial pneumonia

Indexed keywords

C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; FERRITIN; IMMUNOGLOBULIN; KREBS VON DER LUNGEN 6 PROTEIN; METHYLPREDNISOLONE; PREDNISOLONE; PROTEIN; TACROLIMUS; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICALLY AMYOPATHIC DERMATOMYOSITIS; DERMATOMYOSITIS; DIFFUSE ALVEOLAR DAMAGE; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INTERSTITIAL PNEUMONIA; LUNG DISEASE; MALE; MEDICAL RECORD REVIEW; MYOPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SKIN BIOPSY; STEROID THERAPY; SYMPTOM; THORAX RADIOGRAPHY;

ADOLESCENT; AGED; BIOLOGICAL MARKERS; CYCLOPHOSPHAMIDE; DERMATOMYOSITIS; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; FERRITINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PULMONARY ALVEOLI; TREATMENT FAILURE;

EID: 84861479849     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0502-z     Document Type: Article

References (24)

1. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138:1464-74.
2. Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med. 2001; 164:1182-5. (Pubitemid 33052247)
3. Gerami P, Scope JM, McDonald L, Malling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54:597-613.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344-7.
5. Krain L. Dermatomyositis in six patients without initial muscle involvement. Arch Dermatol. 1975;111:241-5.
6. Katzenstein AL, Myers JL, Mazur MT. Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol. 1986;10:256-67. (Pubitemid 16069391)
7. Labirua A, Lundberg IE. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol. 2010;22:633-8.
8. Sato S, Kuwana M. Clinically amyopathic dermatomyositis. Curr Opin Rheumatol. 2010;22:639-43.
9. Gono T, Kawaguchi Y, Hara M, Masuda I, Katsumata Y, Shinozaki M, et al. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology. 2010;49:1354-60.
10. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis. 1990;141:727-33. (Pubitemid 20109165)
11. Bandoh S, Fujita J, Ohtsuki Y, Ueda Y, Hojo S, Tokuda M, et al. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis. Ann Rheum Dis. 2000;59:257-62. (Pubitemid 30305566)
12. Marie I, Dominique S, Remy-Jardin M, Hatron PY, Hachulla E. Interstitial lung diseases in polymyositis and dermatomyositis. Rev Med Interne. 2001;22:1083-96. (Pubitemid 33081266)
13. Schnabel A, Reuter M, Biederer J, Richter C, Gross WL. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum. 2003;32:273-84. (Pubitemid 36459277)
14. Yamasaki Y, Yamada H, Yamasaki M, Ohkubo M, Azuma K, Matsuoka S, et al. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/ dermatomyositis. Rheumatology. 2007;46:124-30. (Pubitemid 44932799)
15. Al-Janadi M, Smith CD, Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol. 1989;16:1592-6. (Pubitemid 20053202)
16. Takada K, Nagasaka K, Miyasaka N. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunity. 2005; 38:383-92. (Pubitemid 41358669)
17. Kotani T, Makino S, Takeuchi T, Kagitani M, Shoda T, Hata A, et al. Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis. J Rheumatol. 2008;35:254-9. (Pubitemid 351284439)
18. Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, et al. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/ polymyositis: prediction and treatment with cyclosporine. J Rheumatol. 1999;26:1527-33. (Pubitemid 29317875)
19. Maeda K, Kimura R, Komuta K, Igarashi T. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis? Scand J Rheumatol. 1997;26:24-9. (Pubitemid 27105157)
20. Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum. 2005;52:2439-46. (Pubitemid 41117430)
21. Ando M, Miyazaki E, Yamasue M, Sadamura Y, Ishii T, Takenaka R, Ito T, et al. Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine. Clin Rheumatol. 2010;29:443-5.
22. Miyazaki E, Ando M, Muramatsu T, et al. Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis. Clin Rheumatol. 2007;26:436-9. (Pubitemid 46486980)
23. Kameda H, Takeuchi T. Recent advances in the treatment of interstitial lung disease in patients with polymyositis/dermatomyositis. Endocr Metab Immune Disord Drug Targets. 2006;6: 409-15. (Pubitemid 44941929)
24. Maccioni FJ, Colebatch HJ. Management of fibrosing alveolitis with polymyositis dermatomyositis. Aust N Z J Med. 1990;20: 806-10.